SEOUL, South Korea — The withdrawal of a major international aid organization threatens to leave tens of thousands of tuberculosis patients in North Korea without the medication they need and could spiral into a severe crisis if it is not addressed soon, according to health experts familiar with the situation in the North.
The dwindling stockpile of crucial medications follows the abrupt departure of the Global Fund to Fight AIDS, Tuberculosis and Malaria, an international aid organization whose grants to North Korea supported the treatment of 120,000 TB patients last year.
Its support officially ended in June despite an outcry among health officials in North Korea and in the international community that it could spark a major epidemic.
Neurosurgeon Kee Park, of the Program in Global Surgery and Social Change at Harvard Medical School, said in an email to The Associated Press that the situation is extremely dire and likely to get dramatically worse in the years ahead if it is not properly dealt with.
The US-based nonprofit Eugene Bell Foundation, which works on the ground treating tuberculosis in North Korea, said Friday that the crisis is being compounded by US-led sanctions over Pyongyang’s nuclear weapons and missile program.
North Korea has one of the world’s highest rates of tuberculosis, a highly infectious disease that, while treatable, globally causes more than 1 million deaths each year.
According to the World Health Organization, about 107,000 cases of tuberculosis were reported in North Korea in 2017.
Making matters worse, North Korea has estimated that 6-7 percent of its tuberculosis population has the drug-resistant variety, known as MDR-TB, which is far more difficult and costly to cure.
“As a result of the loss of the Global Fund grants for the DPRK, we expect a 50-75 percent reduction in treatment capacity for non-MDR-TB patients,” Park said.
“Consequently, our model predicts between 155,000 to 210,000 more people will die from TB-related causes within five years. To be clear, these are new deaths that are expected on top of the current mortality rates. We have assumed that the treatment of MDR-TB will continue at current levels.”
Drug-resistant tuberculosis generally results from patients not taking the proper amount or combination of medications to completely cure them of the disease, or by coming into contact with someone who has been infected with it already.
Disclaimer: The comments uploaded on this site do not necessarily represent or reflect the views of management and owner of Cebudailynews. We reserve the right to exclude comments that we deem to be inconsistent with our editorial standards.
